Baseline characteristics

A Study of Oral AMN107 in Adults With Chronic Myelogenous Leukemia (CML) or Other Hematologic Malignancies · Source last updated 2021-06-29

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

denoms

1. counts

   1. group Id

      BG000

      value

      321

   2. group Id

      BG001

      value

      137

   3. group Id

      BG002

      value

      49

   4. group Id

      BG003

      value

      507

   units

   Participants

groups

1. description

   Adult participants PH+ CML-CP without prior TKI treatment with either resistant / intolerant to Imatinib received 400 mg Nilotinib orally twice daily up to the end of treatment (September-2012).

   id

   BG000

   title

   CML-CP With Prior Imatinib Only

2. description

   Adult participants PH+ CML-AP without prior TKI treatment with either resistant / intolerant to Imatinib received 400 mg Nilotinib orally twice daily up to the end of treatment (September-2012).

   id

   BG001

   title

   CML-AP With Prior Imatinib Only

3. description

   Adult participants PH+ CML-CP in addition to prior TKI treatment with either resistant / intolerant to Imatinib received 400 mg Nilotinib orally twice daily up to the end of treatment (September-2012).

   id

   BG002

   title

   CML-CP

4. description

   Total of all reporting groups

   id

   BG003

   title

   Total

measures

1. classes

   1. categories

      1. measurements

         1. group Id

            BG000

            value

            22

         2. group Id

            BG001

            value

            8

         3. group Id

            BG002

            value

            3

         4. group Id

            BG003

            value

            33

      title

      <35 years

   2. categories

      1. measurements

         1. group Id

            BG000

            value

            104

         2. group Id

            BG001

            value

            49

         3. group Id

            BG002

            value

            16

         4. group Id

            BG003

            value

            169

      title

      ≥35 to <55 years

   3. categories

      1. measurements

         1. group Id

            BG000

            value

            97

         2. group Id

            BG001

            value

            39

         3. group Id

            BG002

            value

            12

         4. group Id

            BG003

            value

            148

      title

      ≥55 to <65 years

   4. categories

      1. measurements

         1. group Id

            BG000

            value

            98

         2. group Id

            BG001

            value

            41

         3. group Id

            BG002

            value

            18

         4. group Id

            BG003

            value

            157

      title

      ≥65 years

   param Type

   COUNT_OF_PARTICIPANTS

   title

   Age, Customized

   unit Of Measure

   Participants

2. classes

   1. categories

      1. measurements

         1. group Id

            BG000

            value

            159

         2. group Id

            BG001

            value

            61

         3. group Id

            BG002

            value

            25

         4. group Id

            BG003

            value

            245

         title

         Female

      2. measurements

         1. group Id

            BG000

            value

            162

         2. group Id

            BG001

            value

            76

         3. group Id

            BG002

            value

            24

         4. group Id

            BG003

            value

            262

         title

         Male

   param Type

   COUNT_OF_PARTICIPANTS

   title

   Sex: Female, Male

   unit Of Measure

   Participants

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Not medical advice